TARSUS PHARMACEUTICALS, INC. (TARS)

Import this data to Google Sheets with:

=jivedata("TARS","financials")

Full statements spill as a table. For one cell: =jivedata("TARS","Revenue") or =jivedata("TARS","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

TARSUS PHARMACEUTICALS, INC.

TARS • CIK 0001819790

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$-143,158	$-120,569	$-70,969	$-48,535
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-135,893	$-115,554	$-64,359	$-64,359
Income Tax Expense (Benefit)	$0	$0	$2,059	$7,127
Net Income (Loss) Attributable to Parent	$-135,893	$-115,554	$-66,418	$-46,476
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax	$72	$181	$202	$-596
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-135,821	$-115,373	$-66,216	$-47,072
Weighted Average Number of Shares Outstanding, Basic	29,383,276	37,604,538	41,784,014	44,091,164
Revenues	$17,447	$182,953	$451,360	$606,331
Research and Development Expense	$50,312	$53,386	$64,322	$87,680
Selling, General and Administrative Expense	$108,700	$237,310	$427,323	$526,441
Costs and Expenses	—	$303,522	$522,329	$654,866
Interest Income, Other	—	$15,014	$15,747	$15,484
InterestExpenseNonoperating	—	$7,849	$8,935	$8,766
Gain (Loss) on Extinguishment of Debt	—	$-1,944	$0	$0
Other Nonoperating Income (Expense)	$-102	$586	$-202	$-344
Nonoperating Income (Expense)	$7,265	$5,015	$6,610	$9,186

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, Fair Value Disclosure	$224,947	$94,819	$183,641	$204,595
Restricted Cash, Current	—	—	$560	$0
Restricted Cash, Noncurrent	—	$2,562	$2,002	$2,001
Marketable Securities, Current	$2,495	$196,557	$233,627	$245,095
Inventory, Noncurrent	—	$2,533	$2,532	$2,525
Accounts Receivable, after Allowance for Credit Loss, Current	$16,621	$46,760	$85,057	$96,028
Property, Plant and Equipment, Net	$1,468	$2,314	$11,665	$20,489
Inventory, Net	$3,107	$2,620	$4,372	$4,377
Intangible Assets, Net (Excluding Goodwill)	$3,867	$8,326	$7,366	$6,885
Other Receivables, Net, Current	$1,093	$1,299	$2,052	$2,281
Operating Lease, Right-of-Use Asset	$1,880	$552	$10,080	$9,911
Prepaid Expense, Current	$7,868	$14,650	$13,473	$9,613
Long-term Investments	$631	$3,000	$3,870	$6,682
Assets, Current	$256,131	$356,705	$522,782	$561,989
Other Assets, Noncurrent	$1,514	$999	$1,861	$660
Assets	$265,491	$376,991	$562,158	$611,142
Long-term Debt, Excluding Current Maturities	$29,819	$71,845	$72,438	$72,762
Other Liabilities, Noncurrent	$1,748	$0	$10,599	$15,895
Liabilities	$68,503	$152,457	$218,732	$264,410
Accounts Payable, Current	—	—	$16,387	$40,141
Employee-related Liabilities, Current	$13,245	$15,823	$17,779	$11,887
Accounts Payable and Other Accrued Liabilities, Current	$23,691	$64,789	$101,529	$123,725
Liabilities, Current	$36,936	$80,612	$135,695	$175,753
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$5	$6	$6	$6
Additional Paid in Capital	$441,641	$584,559	$769,667	$799,429
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-2	$179	$381	$-557
Retained Earnings (Accumulated Deficit)	$-244,656	$-360,210	$-426,628	$-452,146
Stockholders' Equity Attributable to Parent	$196,988	$224,534	$343,426	$346,732
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	200,000,000	200,000,000	200,000,000	200,000,000
Common Stock, Shares, Issued	34,211,190	38,349,826	42,553,931	43,271,347
Inventory, Work in Process, Net of Reserves	$392	$614	$1,410	$1,360
Inventory, Finished Goods, Net of Reserves	$182	$2,006	$2,962	$3,017
Property, Plant and Equipment, Gross	$2,758	$4,290	$13,763	$22,343
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$1,290	$1,976	$2,098	$1,854
Depreciation	$744	$685	$855	$957
Amortization of Intangible Assets	$133	$540	$961	$480
Impairment of Intangible Assets (Excluding Goodwill)	—	$0	$0	$0
Intangible Assets, Gross (Excluding Goodwill)	—	—	$9,000	$9,000
Finite-Lived Intangible Assets, Accumulated Amortization	—	$700	$1,634	$2,115
Finite-Lived Intangible Asset, Expected Amortization, Year One	$400	$961	$961	$961
Finite-Lived Intangible Asset, Expected Amortization, after Year Five	$1,867	$3,521	$2,561	$2,561
Accrued Sales Commission, Current	$4,867	$33,122	$68,439	$86,801
Other Liabilities, Current	—	—	$22,179	$25,430
Taxes Payable, Current	—	—	$1,811	$2,105
Operating Lease, Liability, Current	$398	$608	$0	$154

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$153,287	$-127,566	$88,822	$107,385
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$224,947	$97,381	$186,203	$112,046
Net Income (Loss) Attributable to Parent	$-135,893	$-115,554	$-66,418	$-46,476
Net Cash Provided by (Used in) Operating Activities	$-117,493	$-83,027	$-12,451	$74,158
Proceeds from Sale and Maturity of Marketable Securities	—	$73,000	$361,800	$309,986
Payments to Acquire Debt Securities, Available-for-sale	$28,664	$262,628	$393,186	$267,114
Payments to Acquire Long-term Investments	—	$3,000	$870	$870
Payments to Acquire Intangible Assets	$4,000	$5,000	$0	$0
Payments to Acquire Property, Plant, and Equipment	$1,502	$1,567	$9,859	$18,155
Net Cash Provided by (Used in) Investing Activities	$140,604	$-199,195	$-42,115	$23,847
Proceeds from Issuance of Warrants	—	$9,365	$0	$0
Proceeds from Stock Options Exercised	$592	$5,609	$6,280	$6,706
Proceeds from Stock Plans	—	$1,795	$2,337	$2,674
Proceeds from Issuance of Long-term Debt	—	$75,000	$0	$0
Payments of Debt Issuance Costs	$0	$3,523	$0	$0
Payment for Debt Extinguishment or Debt Prepayment Cost	—	$31,877	$0	$0
Net Cash Provided by (Used in) Financing Activities	$130,176	$154,656	$143,388	$9,380
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$1,846	$384	$10,209	$10,209
Interest Paid, Excluding Capitalized Interest, Operating Activities	$2,880	$7,662	$8,342	$8,133
Capital Expenditures Incurred but Not yet Paid	$134	$99	$1,531	$1,810
Depreciation	$744	$685	$855	$1,379
Amortization of Intangible Assets	$133	$540	$961	$961
Amortization of Debt Issuance Costs and Discounts	$385	$482	$593	$633
Share-based Payment Arrangement, Noncash Expense	$19,830	$27,818	$41,720	$51,813
Gain (Loss) on Extinguishment of Debt	—	$-1,944	$0	$0
Accretion (Amortization) of Discounts and Premiums, Investments	$3,163	$4,213	$5,482	$4,070
Equity Securities, FV-NI, Gain (Loss)	—	$-591	$0	$0
Embedded Derivative, Gain (Loss) on Embedded Derivative, Net	$117	$-201	$0	$0
Increase (Decrease) in Accounts Receivable	$16,621	$30,139	$38,297	$37,695
Increase (Decrease) in Inventories	$3,107	$2,046	$1,751	$497
Increase (Decrease) in Other Receivables	$-2,490	$206	$754	$353
Increase (Decrease) in Prepaid Expense	—	$7,019	$-1,716	$-20,026
Increase (Decrease) in Other Noncurrent Assets	$718	$-572	$527	$558
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities	$13,240	$40,337	$6,906	$16,713
Increase (Decrease) in Employee Related Liabilities	$7,726	$2,578	$1,956	$276
Increase (Decrease) in Other Accrued Liabilities	—	—	$45,389	$60,809
Increase (Decrease) in Other Noncurrent Liabilities	$185	$-233	$0	$0

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("TARS","financials")

Full statements spill as a table. For one cell: =jivedata("TARS","Revenue") or =jivedata("TARS","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.